Ralph V Boccia

Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma.

Blood Cancer J 2019 02 4;9(2):17. Epub 2019 Feb 4.

Sarah Cannon Research Institute, Nashville, TN, USA.

February 2019

Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera in the United States.

Authors:

Michael R Grunwald Brady L Stein Ralph V Boccia Stephen T Oh Dilan Paranagama Shreekant Parasuraman Philomena Colucci Ruben Mesa

Clin Lymphoma Myeloma Leuk 2018 12 29;18(12):788-795.e2. Epub 2018 Aug 29.

San Antonio Cancer Center (an NCI Designated Cancer Center), San Antonio, TX.

View Article and Find Full Text PDF

December 2018

Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States.

Authors:

Ruben Mesa Ralph V Boccia Michael R Grunwald Stephen T Oh Philomena Colucci Dilan Paranagama Shreekant Parasuraman Brady L Stein

Clin Lymphoma Myeloma Leuk 2018 09 28;18(9):590-596. Epub 2018 May 28.

Department of Medicine (Hematology and Oncology), Northwestern University Feinberg School of Medicine, Chicago, IL.

View Article and Find Full Text PDF

September 2018

Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC).

Authors:

John D Hainsworth David M Waterhouse Kent C Shih Ralph V Boccia Victor M Priego Michael J McCleod Fred J Kudrik Reed Brian Mitchell Howard A Burris F Anthony Greco David R Spigel

Lung Cancer 2018 04 31;118:6-12. Epub 2018 Jan 31.

Sarah Cannon Research Institute, Nashville, TN, United States; Tennessee Oncology, PLLC, Nashville, TN, United States.

View Article and Find Full Text PDF

April 2018

Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma.

Authors:

Ian W Flinn Dana S Thompson Ralph V Boccia Gerald Miletello Andrew Lipman Douglas Flora Daniel Cuevas Steven W Papish Jesus G Berdeja

Br J Haematol 2018 02 28;180(3):365-373. Epub 2017 Nov 28.

Sarah Cannon Research Institute/Tennessee Oncology PLLC, Nashville, TN, USA.

View Article and Find Full Text PDF

February 2018

A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2).

Authors:

Ralph V Boccia Alberto Bessudo Richy Agajanian Paul Conkling Wael Harb Hui Yang Dawn Pinchasik Amy S Kimball James R Berenson

Clin Lymphoma Myeloma Leuk 2017 07 10;17(7):433-437. Epub 2017 May 10.

Institute for Myeloma & Bone Cancer Research, West Hollywood, CA.

View Article and Find Full Text PDF

July 2017

Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy.

Authors:

Jesus G Berdeja Todd Bauer Edward Arrowsmith James Essell Patrick Murphy James A Reeves Ralph V Boccia William Donnellan Ian Flinn

Br J Haematol 2017 04 7;177(2):254-262. Epub 2017 Feb 7.

Sarah Cannon Research Institute, Nashville, TN, USA.

View Article and Find Full Text PDF

April 2017

Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma.

Authors:

Sven de Vos Nina D Wagner-Johnston Steven E Coutre Ian W Flinn Marshall T Schreeder Nathan H Fowler Jeff P Sharman Ralph V Boccia Jacqueline C Barrientos Kanti R Rai Thomas E Boyd Richard R Furman Yeonhee Kim Wayne R Godfrey John P Leonard

Blood Adv 2016 Dec 30;1(2):122-131. Epub 2016 Nov 30.

Weill Cornell Medical College, New York, NY; and.

View Article and Find Full Text PDF

December 2016

Efficacy and safety of darbepoetin alfa initiated at hemoglobin ≤10 g/dL in patients with stage IV cancer and chemotherapy-induced anemia.

Authors:

Ralph V Boccia David H Henry Laura Belton Chet Bohac Hassan H Ghazal

Cancer Med 2016 12 23;5(12):3445-3453. Epub 2016 Nov 23.

Kentucky Cancer Clinic, Hazard, Kentucky.

View Article and Find Full Text PDF

December 2016

Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older.

Authors:

Andres Forero-Torres Beata Holkova Jerome Goldschmidt Robert Chen Gregg Olsen Ralph V Boccia Rodolfo E Bordoni Jonathan W Friedberg Jeff P Sharman Maria Corinna Palanca-Wessels Yinghui Wang Christopher A Yasenchak

Blood 2015 Dec 16;126(26):2798-804. Epub 2015 Sep 16.

Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR; and.

View Article and Find Full Text PDF

December 2015

Translating Research into Practice: the Prosigna® (PAM50) Gene Signature Assay.

Authors:

Ralph V Boccia

Clin Adv Hematol Oncol 2015 Jun;13(6 Suppl 6):3-13

Center for Cancer and Blood Disorders, Bethesda, Maryland, Georgetown University, Washington, DC.

View Article and Find Full Text PDF

June 2015

Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity.

Authors:

Ann Janssens Michael Tarantino Robert J Bird Maria Gabriella Mazzucconi Ralph V Boccia Maria Fernanda López Fernández Tomas Kozak Michael Steurer Peter te Boekhorst Kerry Dillingham Georg Kreuzbauer Paul Woodard

Acta Haematol 2015 ;134(4):215-28

View Article and Find Full Text PDF

April 2016

Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials.

Authors:

José M Garcia Ralph V Boccia Charles D Graham Ying Yan Elizabeth Manning Duus Suzan Allen John Friend

Lancet Oncol 2015 Jan 16;16(1):108-16. Epub 2014 Dec 16.

Helsinn Therapeutics (US), Bridgewater, NJ, USA.

View Article and Find Full Text PDF

January 2015

Evolving strategies for the management of multiple myeloma: a managed care perspective.

Authors:

Ira M Klein Ralph V Boccia Eric Cannon William J Cardarelli Bo Gamble Linda House David H Howard Mary Malloy R Denise McAllister Brenda Milota Gary Rice Michele Rice

Am J Manag Care 2014 Feb;20(2 Suppl):s45-60

View Article and Find Full Text PDF

February 2014

A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myeloma.

Authors:

James R Berenson James D Hilger Ori Yellin Ralph V Boccia Jeffrey Matous Kenneth Dressler Hassan H Ghazal Saad Jamshed Edwin C Kingsley Wael A Harb Stephen J Noga Youram Nassir Regina A Swift Robert Vescio

Ann Hematol 2014 Jan 18;93(1):89-98. Epub 2013 Oct 18.

Oncotherapeutics, Los Angeles, CA, USA,

View Article and Find Full Text PDF

January 2014

Reply to M.-E. Percival et al and L.B. Saltz.

Authors:

John D Hainsworth David R Spigel Mark S Rubin Ralph V Boccia F Anthony Greco

J Clin Oncol 2013 Jul;31(19):2514-5

View Article and Find Full Text PDF

July 2013

The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors.

Authors:

Lee S Rosen Lara Lipton Timothy J Price Neil D Belman Ralph V Boccia Herbert I Hurwitz Joe J Stephenson Lori J Wirth Sheryl McCoy Yong-Jiang Hei Cheng-Pang Hsu Niall C Tebbutt

BMC Cancer 2013 May 16;13:242. Epub 2013 May 16.

Department of Medicine, University of California Los Angeles, Santa Monica, CA, USA.

View Article and Find Full Text PDF

May 2013

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.

Authors:

Adrian S Dobs Ralph V Boccia Christopher C Croot Nashat Y Gabrail James T Dalton Michael L Hancock Mary A Johnston Mitchell S Steiner

Lancet Oncol 2013 Apr 14;14(4):335-45. Epub 2013 Mar 14.

Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

View Article and Find Full Text PDF

April 2013

Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.

Authors:

James R Berenson Ori Yellin Alberto Bessudo Ralph V Boccia Stephen J Noga Donald S Gravenor Dipti Patel-Donnelly Robert S Siegel Tarun Kewalramani Edward J Gorak Youram Nassir Regina A Swift Debra Mayo

Br J Haematol 2013 Feb 15;160(3):321-30. Epub 2012 Nov 15.

Oncotherapeutics, Institute for Myeloma & Bone Cancer Research, 9201 W. Sunset Blvd, West Hollywood, CA 90069, USA.

View Article and Find Full Text PDF

February 2013

Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute.

Authors:

John D Hainsworth Mark S Rubin David R Spigel Ralph V Boccia Samuel Raby Raven Quinn F Anthony Greco

J Clin Oncol 2013 Jan 1;31(2):217-23. Epub 2012 Oct 1.

Sarah Cannon Research Institute, Nashville, TN 37203, USA.

View Article and Find Full Text PDF

January 2013

Publications by authors named "Ralph V Boccia"

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors: